Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatic Cyst | 71 | 2022 | 371 | 12.150 |
Why?
|
Endosonography | 89 | 2017 | 626 | 11.570 |
Why?
|
Pancreatic Neoplasms | 103 | 2024 | 5443 | 6.240 |
Why?
|
Pancreas | 46 | 2022 | 1700 | 4.460 |
Why?
|
Cyst Fluid | 21 | 2022 | 85 | 3.840 |
Why?
|
Carcinoma, Pancreatic Ductal | 26 | 2024 | 1756 | 2.510 |
Why?
|
Adenocarcinoma, Mucinous | 20 | 2024 | 526 | 2.480 |
Why?
|
Carcinoembryonic Antigen | 17 | 2018 | 338 | 2.470 |
Why?
|
Bile Ducts | 9 | 2017 | 288 | 2.340 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 8 | 2018 | 196 | 2.100 |
Why?
|
Pancreatic Diseases | 12 | 2017 | 353 | 1.880 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 18 | 2015 | 520 | 1.800 |
Why?
|
Biopsy, Fine-Needle | 22 | 2017 | 1132 | 1.700 |
Why?
|
Cystadenoma, Serous | 12 | 2021 | 100 | 1.660 |
Why?
|
Catheter Ablation | 15 | 2017 | 2780 | 1.500 |
Why?
|
Biliary Tract Neoplasms | 5 | 2016 | 187 | 1.490 |
Why?
|
Cholestasis | 5 | 2016 | 385 | 1.460 |
Why?
|
Colonic Polyps | 4 | 2024 | 557 | 1.460 |
Why?
|
Neuroendocrine Tumors | 7 | 2018 | 657 | 1.420 |
Why?
|
Ethanol | 9 | 2012 | 1331 | 1.350 |
Why?
|
Pancreatitis | 15 | 2017 | 1087 | 1.310 |
Why?
|
Endoscopy, Digestive System | 12 | 2016 | 358 | 1.290 |
Why?
|
Gastroscopy | 7 | 2016 | 213 | 1.230 |
Why?
|
Microscopy, Confocal | 8 | 2017 | 1973 | 1.170 |
Why?
|
Pancreatectomy | 12 | 2021 | 825 | 1.150 |
Why?
|
Biliary Tract Diseases | 5 | 2013 | 159 | 1.090 |
Why?
|
Endoscopy, Gastrointestinal | 10 | 2009 | 888 | 1.090 |
Why?
|
Pancreatitis, Chronic | 8 | 2013 | 282 | 1.090 |
Why?
|
Cystadenoma, Mucinous | 9 | 2009 | 62 | 1.030 |
Why?
|
Adenoma | 4 | 2024 | 2163 | 0.990 |
Why?
|
Bile Duct Neoplasms | 5 | 2017 | 615 | 0.990 |
Why?
|
Biopsy, Needle | 17 | 2009 | 1626 | 0.970 |
Why?
|
Portal Vein | 6 | 2008 | 435 | 0.950 |
Why?
|
Adenocarcinoma | 19 | 2015 | 6401 | 0.900 |
Why?
|
Surgical Instruments | 3 | 2018 | 386 | 0.890 |
Why?
|
Cystadenoma | 6 | 2018 | 77 | 0.880 |
Why?
|
Gastric Mucosa | 6 | 2016 | 602 | 0.880 |
Why?
|
Swine | 29 | 2015 | 5997 | 0.870 |
Why?
|
Gastrointestinal Neoplasms | 5 | 2013 | 957 | 0.860 |
Why?
|
Carcinoma, Papillary | 9 | 2017 | 793 | 0.840 |
Why?
|
Gastrointestinal Stromal Tumors | 4 | 2016 | 617 | 0.830 |
Why?
|
Stomach Neoplasms | 9 | 2016 | 1483 | 0.800 |
Why?
|
Thoracoscopy | 4 | 2011 | 186 | 0.790 |
Why?
|
Autoimmune Diseases | 12 | 2017 | 2258 | 0.790 |
Why?
|
Esophagus | 15 | 2013 | 1043 | 0.790 |
Why?
|
Esophagoscopy | 7 | 2013 | 398 | 0.780 |
Why?
|
Pancreatic Pseudocyst | 7 | 2017 | 112 | 0.760 |
Why?
|
Pancreatic Ducts | 7 | 2017 | 330 | 0.740 |
Why?
|
Amylases | 6 | 2016 | 171 | 0.730 |
Why?
|
Cytodiagnosis | 8 | 2015 | 453 | 0.720 |
Why?
|
Esophageal Neoplasms | 12 | 2015 | 1674 | 0.710 |
Why?
|
Colonoscopy | 4 | 2024 | 1410 | 0.680 |
Why?
|
Endoscopy | 9 | 2017 | 1862 | 0.660 |
Why?
|
Ablation Techniques | 2 | 2013 | 255 | 0.660 |
Why?
|
Ultrasonography, Interventional | 7 | 2012 | 1524 | 0.650 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2024 | 709 | 0.650 |
Why?
|
Drainage | 6 | 2017 | 1184 | 0.650 |
Why?
|
Sensitivity and Specificity | 38 | 2019 | 14752 | 0.640 |
Why?
|
Barrett Esophagus | 7 | 2015 | 495 | 0.620 |
Why?
|
Stomach | 7 | 2009 | 702 | 0.610 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 6 | 2014 | 100 | 0.610 |
Why?
|
Photochemotherapy | 4 | 2012 | 830 | 0.590 |
Why?
|
Diagnosis, Differential | 33 | 2017 | 13021 | 0.590 |
Why?
|
Gallstones | 3 | 2013 | 285 | 0.550 |
Why?
|
Chromogranins | 2 | 2016 | 160 | 0.540 |
Why?
|
Humans | 216 | 2024 | 768970 | 0.530 |
Why?
|
Therapeutic Irrigation | 4 | 2011 | 297 | 0.520 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 2 | 2016 | 194 | 0.500 |
Why?
|
Natural Orifice Endoscopic Surgery | 3 | 2011 | 119 | 0.480 |
Why?
|
Adenocarcinoma, Papillary | 2 | 2014 | 86 | 0.480 |
Why?
|
Tomography, X-Ray Computed | 34 | 2017 | 20776 | 0.470 |
Why?
|
Catheters | 1 | 2017 | 427 | 0.470 |
Why?
|
Video Recording | 3 | 2009 | 976 | 0.460 |
Why?
|
Prosthesis Failure | 2 | 2016 | 1209 | 0.450 |
Why?
|
Stents | 7 | 2015 | 3200 | 0.450 |
Why?
|
Neoplasm Seeding | 1 | 2014 | 85 | 0.450 |
Why?
|
Leiomyoma | 2 | 2016 | 644 | 0.440 |
Why?
|
Sphincterotomy, Endoscopic | 2 | 2012 | 44 | 0.430 |
Why?
|
Gastrointestinal Diseases | 3 | 2017 | 1204 | 0.430 |
Why?
|
Feasibility Studies | 15 | 2018 | 5323 | 0.430 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 6 | 2016 | 1769 | 0.420 |
Why?
|
Aged | 79 | 2024 | 171786 | 0.410 |
Why?
|
Middle Aged | 98 | 2024 | 223737 | 0.410 |
Why?
|
Aged, 80 and over | 46 | 2019 | 59739 | 0.400 |
Why?
|
Catheterization | 7 | 2009 | 1431 | 0.400 |
Why?
|
Tomography, Optical Coherence | 4 | 2014 | 2957 | 0.390 |
Why?
|
Male | 116 | 2024 | 365203 | 0.390 |
Why?
|
Biopsy | 10 | 2018 | 6805 | 0.390 |
Why?
|
Mucous Membrane | 4 | 2010 | 659 | 0.380 |
Why?
|
Abdominal Pain | 4 | 2013 | 1070 | 0.370 |
Why?
|
Gastroenterology | 2 | 2017 | 593 | 0.370 |
Why?
|
Ampulla of Vater | 5 | 2014 | 150 | 0.360 |
Why?
|
Feedback | 1 | 2014 | 799 | 0.360 |
Why?
|
Equipment Design | 9 | 2017 | 3530 | 0.360 |
Why?
|
Diagnostic Imaging | 5 | 2017 | 3538 | 0.350 |
Why?
|
Female | 106 | 2024 | 397515 | 0.350 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2011 | 70 | 0.350 |
Why?
|
Nerve Block | 4 | 2017 | 716 | 0.350 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2014 | 592 | 0.340 |
Why?
|
Needles | 5 | 2021 | 461 | 0.340 |
Why?
|
Mediastinoscopy | 4 | 2011 | 29 | 0.340 |
Why?
|
Rectal Neoplasms | 2 | 2009 | 1183 | 0.340 |
Why?
|
Lasers, Solid-State | 1 | 2012 | 183 | 0.330 |
Why?
|
Hyperhidrosis | 1 | 2009 | 34 | 0.330 |
Why?
|
Sympathectomy | 1 | 2009 | 72 | 0.330 |
Why?
|
Colorectal Neoplasms | 3 | 2024 | 6982 | 0.320 |
Why?
|
Suture Anchors | 1 | 2009 | 81 | 0.320 |
Why?
|
Dissection | 1 | 2011 | 299 | 0.320 |
Why?
|
Forecasting | 2 | 2017 | 2945 | 0.320 |
Why?
|
Celiac Plexus | 1 | 2009 | 34 | 0.320 |
Why?
|
Splenic Vein | 2 | 2007 | 30 | 0.320 |
Why?
|
Epithelial Cells | 5 | 2017 | 3702 | 0.310 |
Why?
|
Sclerotherapy | 2 | 2008 | 183 | 0.310 |
Why?
|
Paclitaxel | 2 | 2006 | 1735 | 0.310 |
Why?
|
Transducers | 2 | 2007 | 245 | 0.310 |
Why?
|
Microspheres | 2 | 2011 | 789 | 0.300 |
Why?
|
Polyvinyls | 2 | 2007 | 156 | 0.300 |
Why?
|
Hypertension, Portal | 2 | 2008 | 230 | 0.300 |
Why?
|
Sodium Chloride | 2 | 2009 | 584 | 0.290 |
Why?
|
Incidental Findings | 5 | 2018 | 697 | 0.290 |
Why?
|
Peritoneal Neoplasms | 1 | 2014 | 714 | 0.280 |
Why?
|
Pharmaceutical Solutions | 1 | 2007 | 15 | 0.280 |
Why?
|
Gastrostomy | 1 | 2010 | 325 | 0.280 |
Why?
|
Camptothecin | 1 | 2011 | 600 | 0.280 |
Why?
|
Common Bile Duct Neoplasms | 3 | 2014 | 121 | 0.280 |
Why?
|
Early Detection of Cancer | 4 | 2022 | 3238 | 0.280 |
Why?
|
Pyloric Stenosis | 1 | 2006 | 28 | 0.270 |
Why?
|
Lymph Nodes | 3 | 2009 | 3473 | 0.270 |
Why?
|
Disease Management | 1 | 2017 | 2537 | 0.270 |
Why?
|
Embolization, Therapeutic | 2 | 2007 | 1410 | 0.270 |
Why?
|
Gastric Outlet Obstruction | 1 | 2006 | 55 | 0.260 |
Why?
|
Necrosis | 4 | 2013 | 1620 | 0.260 |
Why?
|
Porphyrins | 1 | 2008 | 352 | 0.250 |
Why?
|
Hepatic Encephalopathy | 1 | 2007 | 144 | 0.250 |
Why?
|
Cystadenocarcinoma | 4 | 2006 | 54 | 0.250 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2005 | 45 | 0.240 |
Why?
|
Retrospective Studies | 38 | 2024 | 81903 | 0.240 |
Why?
|
Biliary Tract | 3 | 2015 | 135 | 0.240 |
Why?
|
Animals | 36 | 2015 | 169335 | 0.240 |
Why?
|
Adult | 58 | 2018 | 223851 | 0.230 |
Why?
|
Radiography, Abdominal | 1 | 2008 | 541 | 0.230 |
Why?
|
Precancerous Conditions | 5 | 2017 | 985 | 0.230 |
Why?
|
Cystadenocarcinoma, Mucinous | 3 | 2013 | 51 | 0.230 |
Why?
|
Tuberculosis, Lymph Node | 1 | 2004 | 21 | 0.230 |
Why?
|
Models, Animal | 7 | 2010 | 2122 | 0.230 |
Why?
|
Computers | 2 | 2023 | 592 | 0.220 |
Why?
|
Ganglia, Sympathetic | 2 | 2013 | 65 | 0.220 |
Why?
|
Photosensitizing Agents | 1 | 2008 | 630 | 0.220 |
Why?
|
Rectum | 3 | 2017 | 900 | 0.220 |
Why?
|
Injections, Intralesional | 3 | 2012 | 280 | 0.220 |
Why?
|
Pilot Projects | 7 | 2017 | 8748 | 0.220 |
Why?
|
Neoplasm Staging | 16 | 2009 | 11262 | 0.210 |
Why?
|
ras Proteins | 2 | 2009 | 1058 | 0.210 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2006 | 622 | 0.210 |
Why?
|
Anti-Infective Agents, Local | 1 | 2005 | 247 | 0.210 |
Why?
|
Practice Guidelines as Topic | 7 | 2013 | 7460 | 0.210 |
Why?
|
Follow-Up Studies | 21 | 2024 | 39394 | 0.210 |
Why?
|
Mutation | 6 | 2016 | 30266 | 0.200 |
Why?
|
Prospective Studies | 22 | 2021 | 54962 | 0.200 |
Why?
|
Laparoscopy | 4 | 2009 | 2055 | 0.200 |
Why?
|
Treatment Outcome | 22 | 2016 | 65480 | 0.200 |
Why?
|
Disease Models, Animal | 10 | 2015 | 18354 | 0.200 |
Why?
|
Injections | 3 | 2011 | 841 | 0.190 |
Why?
|
Loss of Heterozygosity | 3 | 2015 | 663 | 0.190 |
Why?
|
CA-19-9 Antigen | 3 | 2006 | 108 | 0.190 |
Why?
|
Esophageal Diseases | 3 | 2009 | 168 | 0.190 |
Why?
|
Mucins | 4 | 2009 | 571 | 0.190 |
Why?
|
Gallbladder Neoplasms | 1 | 2003 | 190 | 0.180 |
Why?
|
Liver | 4 | 2013 | 7578 | 0.170 |
Why?
|
Algorithms | 10 | 2019 | 14201 | 0.170 |
Why?
|
Reproducibility of Results | 13 | 2017 | 20245 | 0.170 |
Why?
|
Cholecystitis | 2 | 1994 | 181 | 0.170 |
Why?
|
Blood Pressure Determination | 1 | 2004 | 646 | 0.170 |
Why?
|
Cholecystokinin | 4 | 1991 | 115 | 0.170 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3044 | 0.170 |
Why?
|
Cholangiocarcinoma | 1 | 2005 | 562 | 0.170 |
Why?
|
Recurrence | 5 | 2016 | 8513 | 0.170 |
Why?
|
Predictive Value of Tests | 13 | 2019 | 15471 | 0.160 |
Why?
|
Prognosis | 16 | 2018 | 30046 | 0.160 |
Why?
|
Immunoglobulin G | 6 | 2012 | 4568 | 0.160 |
Why?
|
Stomach Diseases | 2 | 2016 | 134 | 0.160 |
Why?
|
DNA, Neoplasm | 3 | 2016 | 1748 | 0.160 |
Why?
|
Tumor Burden | 2 | 2016 | 1913 | 0.160 |
Why?
|
Colon, Sigmoid | 2 | 2010 | 124 | 0.160 |
Why?
|
Immunohistochemistry | 7 | 2016 | 11116 | 0.150 |
Why?
|
Postoperative Complications | 13 | 2016 | 15889 | 0.150 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2015 | 2525 | 0.150 |
Why?
|
Duodenum | 5 | 1996 | 495 | 0.140 |
Why?
|
Pressure | 3 | 2010 | 1172 | 0.140 |
Why?
|
Ultrasonography | 12 | 2010 | 6002 | 0.140 |
Why?
|
Preoperative Care | 5 | 2014 | 2258 | 0.140 |
Why?
|
Gallbladder | 2 | 1991 | 308 | 0.140 |
Why?
|
Risk Assessment | 8 | 2017 | 24333 | 0.140 |
Why?
|
Medical Oncology | 1 | 2009 | 2350 | 0.140 |
Why?
|
Suction | 3 | 2017 | 268 | 0.140 |
Why?
|
Random Allocation | 3 | 2011 | 2394 | 0.130 |
Why?
|
Cysts | 1 | 2021 | 685 | 0.130 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2017 | 957 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 2 | 2009 | 4528 | 0.130 |
Why?
|
Decision Making | 1 | 2010 | 3953 | 0.130 |
Why?
|
Lymphatic Metastasis | 3 | 2009 | 2916 | 0.130 |
Why?
|
ROC Curve | 4 | 2015 | 3629 | 0.130 |
Why?
|
Terminology as Topic | 2 | 2014 | 1541 | 0.130 |
Why?
|
Bile | 2 | 1994 | 299 | 0.130 |
Why?
|
Hirschsprung Disease | 1 | 2017 | 163 | 0.130 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2017 | 219 | 0.130 |
Why?
|
Schilling Test | 2 | 1988 | 3 | 0.130 |
Why?
|
Lipase | 2 | 2006 | 321 | 0.120 |
Why?
|
Palliative Care | 1 | 2010 | 3644 | 0.120 |
Why?
|
Pathology, Surgical | 2 | 2009 | 150 | 0.120 |
Why?
|
Radioimmunoassay | 3 | 2011 | 862 | 0.120 |
Why?
|
Trypsin | 6 | 1988 | 491 | 0.120 |
Why?
|
Acute Disease | 4 | 2013 | 7245 | 0.120 |
Why?
|
Cholecystectomy, Laparoscopic | 2 | 1994 | 236 | 0.120 |
Why?
|
Plasma Cells | 3 | 2008 | 599 | 0.120 |
Why?
|
Lymphoid Tissue | 1 | 2016 | 446 | 0.120 |
Why?
|
Choristoma | 1 | 2016 | 205 | 0.120 |
Why?
|
Biliary Tract Surgical Procedures | 1 | 1994 | 50 | 0.120 |
Why?
|
Antineoplastic Agents | 2 | 2009 | 13698 | 0.120 |
Why?
|
Ultrasonics | 1 | 2015 | 208 | 0.120 |
Why?
|
Enteric Nervous System | 1 | 2017 | 213 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2004 | 1321 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 16 | 2017 | 36854 | 0.110 |
Why?
|
Prednisone | 2 | 2010 | 1567 | 0.110 |
Why?
|
Cryosurgery | 2 | 2009 | 477 | 0.110 |
Why?
|
Radiography | 4 | 2010 | 6991 | 0.110 |
Why?
|
Lithotripsy | 3 | 2005 | 141 | 0.110 |
Why?
|
Radio Waves | 1 | 2015 | 254 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2010 | 10765 | 0.110 |
Why?
|
Neoplasm Invasiveness | 8 | 2013 | 3629 | 0.110 |
Why?
|
Colic | 1 | 2013 | 44 | 0.110 |
Why?
|
Intraoperative Complications | 3 | 2009 | 1176 | 0.110 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2015 | 3671 | 0.100 |
Why?
|
Mycobacterium tuberculosis | 1 | 2004 | 1930 | 0.100 |
Why?
|
Pancreatic Function Tests | 3 | 1999 | 69 | 0.100 |
Why?
|
Constipation | 1 | 2017 | 570 | 0.100 |
Why?
|
Genes, BRCA2 | 1 | 2015 | 593 | 0.100 |
Why?
|
Colonic Neoplasms | 1 | 2024 | 2543 | 0.100 |
Why?
|
Sex Factors | 2 | 2024 | 10633 | 0.100 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2014 | 219 | 0.100 |
Why?
|
Neoplasms | 3 | 2012 | 22389 | 0.100 |
Why?
|
Safety | 3 | 2009 | 1161 | 0.100 |
Why?
|
Age Factors | 3 | 2024 | 18435 | 0.100 |
Why?
|
Cholangiography | 2 | 2006 | 182 | 0.100 |
Why?
|
Antibody Specificity | 1 | 2013 | 1065 | 0.100 |
Why?
|
Probability | 3 | 2009 | 2483 | 0.090 |
Why?
|
Survival Rate | 4 | 2016 | 12873 | 0.090 |
Why?
|
Sus scrofa | 3 | 2010 | 430 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2017 | 2848 | 0.090 |
Why?
|
Microsatellite Instability | 1 | 2015 | 726 | 0.090 |
Why?
|
Statistics, Nonparametric | 2 | 2013 | 2862 | 0.090 |
Why?
|
Clinical Competence | 3 | 2024 | 4860 | 0.090 |
Why?
|
Image Enhancement | 2 | 2013 | 2898 | 0.090 |
Why?
|
Fluoroscopy | 2 | 2013 | 947 | 0.090 |
Why?
|
Angiography | 3 | 2010 | 1598 | 0.090 |
Why?
|
Cholelithiasis | 4 | 1993 | 408 | 0.090 |
Why?
|
Mesenteric Artery, Superior | 1 | 2010 | 96 | 0.090 |
Why?
|
Proctoscopy | 1 | 2010 | 40 | 0.090 |
Why?
|
Gastrointestinal Motility | 3 | 1987 | 235 | 0.080 |
Why?
|
Sampling Studies | 3 | 2013 | 615 | 0.080 |
Why?
|
Young Adult | 10 | 2017 | 60131 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 2 | 2010 | 1892 | 0.080 |
Why?
|
Lymph Node Excision | 3 | 2010 | 1273 | 0.080 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 840 | 0.080 |
Why?
|
Diathermy | 1 | 2009 | 17 | 0.080 |
Why?
|
Paraproteinemias | 1 | 2012 | 252 | 0.080 |
Why?
|
Polyps | 1 | 2011 | 200 | 0.080 |
Why?
|
Digestion | 2 | 1986 | 53 | 0.080 |
Why?
|
Peritoneal Cavity | 1 | 2009 | 135 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2013 | 498 | 0.080 |
Why?
|
Constriction, Pathologic | 1 | 2013 | 1104 | 0.080 |
Why?
|
Pancreatic Extracts | 1 | 1988 | 6 | 0.080 |
Why?
|
Pancreatin | 1 | 1988 | 8 | 0.080 |
Why?
|
Guaiac | 1 | 2008 | 13 | 0.080 |
Why?
|
Pancreatic Juice | 2 | 1986 | 60 | 0.080 |
Why?
|
Heterozygote | 1 | 2015 | 2798 | 0.080 |
Why?
|
Clinical Chemistry Tests | 1 | 2008 | 59 | 0.080 |
Why?
|
Radionuclide Imaging | 5 | 2007 | 1998 | 0.080 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2010 | 180 | 0.080 |
Why?
|
Intestinal Secretions | 1 | 1988 | 15 | 0.080 |
Why?
|
Lactoglobulins | 1 | 1988 | 22 | 0.080 |
Why?
|
Time Factors | 8 | 2024 | 40261 | 0.080 |
Why?
|
Carcinoid Tumor | 1 | 2010 | 224 | 0.080 |
Why?
|
Genetic Markers | 1 | 2014 | 2604 | 0.080 |
Why?
|
Burns | 2 | 2011 | 1901 | 0.080 |
Why?
|
Intestinal Absorption | 2 | 1987 | 400 | 0.080 |
Why?
|
Mass Screening | 2 | 2014 | 5457 | 0.080 |
Why?
|
Iodine | 1 | 2010 | 286 | 0.080 |
Why?
|
Chymotrypsin | 1 | 1988 | 137 | 0.070 |
Why?
|
Esophagectomy | 2 | 2009 | 482 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4124 | 0.070 |
Why?
|
Esophageal Achalasia | 1 | 1989 | 99 | 0.070 |
Why?
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 2 | 2017 | 26 | 0.070 |
Why?
|
Pliability | 1 | 2007 | 58 | 0.070 |
Why?
|
Aorta, Abdominal | 1 | 2010 | 627 | 0.070 |
Why?
|
Lipoma | 1 | 2010 | 296 | 0.070 |
Why?
|
Ulcer | 1 | 2009 | 203 | 0.070 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 1988 | 84 | 0.070 |
Why?
|
Occult Blood | 1 | 2008 | 199 | 0.070 |
Why?
|
Lactoferrin | 1 | 1988 | 100 | 0.070 |
Why?
|
Microsurgery | 2 | 2010 | 803 | 0.070 |
Why?
|
Venous Pressure | 1 | 2007 | 55 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2002 | 3200 | 0.070 |
Why?
|
Immune Complex Diseases | 1 | 2006 | 50 | 0.070 |
Why?
|
Contrast Media | 2 | 2010 | 5334 | 0.070 |
Why?
|
Solvents | 1 | 2008 | 298 | 0.070 |
Why?
|
Biliary Dyskinesia | 1 | 1986 | 3 | 0.070 |
Why?
|
Esophagogastric Junction | 1 | 1989 | 351 | 0.070 |
Why?
|
Atrial Fibrillation | 3 | 2011 | 5176 | 0.070 |
Why?
|
Endoscopes | 1 | 2007 | 169 | 0.070 |
Why?
|
Carbohydrate Metabolism | 1 | 1987 | 262 | 0.070 |
Why?
|
Metals | 1 | 2010 | 713 | 0.070 |
Why?
|
Cholecystectomy | 2 | 2003 | 409 | 0.060 |
Why?
|
Viscosity | 1 | 2006 | 334 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 1997 | 1941 | 0.060 |
Why?
|
Injections, Intravenous | 1 | 2008 | 1379 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2002 | 4300 | 0.060 |
Why?
|
Intracranial Embolism | 1 | 2007 | 189 | 0.060 |
Why?
|
Antibodies | 1 | 2013 | 2422 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 4 | 2009 | 1126 | 0.060 |
Why?
|
Hyperthermia, Induced | 1 | 2009 | 416 | 0.060 |
Why?
|
gamma-Globulins | 1 | 2004 | 119 | 0.060 |
Why?
|
Body Temperature | 1 | 2008 | 781 | 0.060 |
Why?
|
Duodenoscopes | 1 | 2005 | 43 | 0.060 |
Why?
|
Peptic Ulcer | 1 | 2006 | 215 | 0.060 |
Why?
|
Choledocholithiasis | 1 | 2005 | 50 | 0.060 |
Why?
|
Jejunum | 1 | 1987 | 475 | 0.060 |
Why?
|
Equipment Failure | 1 | 2007 | 585 | 0.060 |
Why?
|
Boston | 3 | 2017 | 9377 | 0.060 |
Why?
|
Lasers | 1 | 2009 | 952 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 9080 | 0.060 |
Why?
|
Morocco | 1 | 2004 | 36 | 0.060 |
Why?
|
Smad4 Protein | 2 | 2015 | 193 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 2 | 2012 | 1811 | 0.060 |
Why?
|
Postoperative Care | 1 | 2011 | 1481 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3628 | 0.060 |
Why?
|
Movement | 1 | 1991 | 1490 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2015 | 2238 | 0.060 |
Why?
|
Cytoplasm | 1 | 2009 | 1505 | 0.060 |
Why?
|
Carcinoma, Ductal | 1 | 2004 | 97 | 0.060 |
Why?
|
Polyvinyl Alcohol | 1 | 2004 | 74 | 0.060 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 2004 | 137 | 0.050 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1232 | 0.050 |
Why?
|
Heart Neoplasms | 1 | 2007 | 374 | 0.050 |
Why?
|
Wound Healing | 2 | 2011 | 2815 | 0.050 |
Why?
|
Cimetidine | 1 | 1982 | 76 | 0.050 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2006 | 1536 | 0.050 |
Why?
|
Gallbladder Emptying | 2 | 1993 | 14 | 0.050 |
Why?
|
Helicobacter pylori | 1 | 2006 | 380 | 0.050 |
Why?
|
Incidence | 5 | 2024 | 21547 | 0.050 |
Why?
|
Helicobacter Infections | 1 | 2006 | 390 | 0.050 |
Why?
|
Postoperative Period | 1 | 2008 | 1830 | 0.050 |
Why?
|
Body Fluids | 1 | 2004 | 322 | 0.050 |
Why?
|
Cohort Studies | 7 | 2016 | 41808 | 0.050 |
Why?
|
Morbidity | 1 | 2007 | 1757 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2009 | 12467 | 0.050 |
Why?
|
Biomedical Research | 1 | 2017 | 3463 | 0.050 |
Why?
|
Guanidines | 1 | 1982 | 194 | 0.050 |
Why?
|
Hepatectomy | 1 | 2005 | 588 | 0.050 |
Why?
|
Monitoring, Intraoperative | 1 | 2008 | 950 | 0.050 |
Why?
|
Gallbladder Diseases | 1 | 2003 | 139 | 0.050 |
Why?
|
Observer Variation | 3 | 2017 | 2623 | 0.050 |
Why?
|
Alcoholism | 3 | 1988 | 1981 | 0.050 |
Why?
|
Cell Biology | 1 | 2002 | 92 | 0.050 |
Why?
|
Manometry | 2 | 2017 | 459 | 0.050 |
Why?
|
Credentialing | 1 | 2001 | 114 | 0.050 |
Why?
|
Amyloidosis | 1 | 1989 | 879 | 0.050 |
Why?
|
Colon | 1 | 1989 | 1803 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1997 | 4064 | 0.050 |
Why?
|
Immunologic Factors | 1 | 2010 | 1597 | 0.050 |
Why?
|
Health Care Costs | 2 | 2009 | 3270 | 0.050 |
Why?
|
Emigration and Immigration | 1 | 2004 | 407 | 0.050 |
Why?
|
Lymphogranuloma Venereum | 1 | 1980 | 14 | 0.050 |
Why?
|
Heart Atria | 1 | 2007 | 1361 | 0.050 |
Why?
|
Echocardiography, Transesophageal | 1 | 2007 | 1096 | 0.050 |
Why?
|
Intrinsic Factor | 1 | 1980 | 4 | 0.040 |
Why?
|
Chronic Disease | 5 | 2005 | 9384 | 0.040 |
Why?
|
SEER Program | 2 | 2016 | 1473 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2005 | 888 | 0.040 |
Why?
|
Transcobalamins | 1 | 1980 | 22 | 0.040 |
Why?
|
Proctitis | 1 | 1980 | 40 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2009 | 15951 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6856 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6547 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2009 | 2885 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2008 | 6673 | 0.040 |
Why?
|
Homosexuality | 1 | 1980 | 269 | 0.040 |
Why?
|
Confidence Intervals | 3 | 2013 | 2932 | 0.040 |
Why?
|
Research Design | 1 | 2015 | 6214 | 0.040 |
Why?
|
Societies, Medical | 3 | 2017 | 3968 | 0.040 |
Why?
|
Intestine, Small | 2 | 1999 | 1218 | 0.040 |
Why?
|
Bariatric Surgery | 1 | 2009 | 1001 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 8055 | 0.040 |
Why?
|
Risk | 3 | 2015 | 9621 | 0.040 |
Why?
|
Pancreaticoduodenectomy | 1 | 2021 | 516 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2008 | 2784 | 0.040 |
Why?
|
Esophageal and Gastric Varices | 1 | 1999 | 215 | 0.040 |
Why?
|
Disease Progression | 3 | 2024 | 13674 | 0.040 |
Why?
|
Gastric Juice | 2 | 1988 | 59 | 0.040 |
Why?
|
Deglutition Disorders | 2 | 1996 | 641 | 0.040 |
Why?
|
Vitamin B 12 | 1 | 1980 | 529 | 0.030 |
Why?
|
Carcinoma in Situ | 2 | 2013 | 788 | 0.030 |
Why?
|
Adenoma, Islet Cell | 1 | 1996 | 72 | 0.030 |
Why?
|
Lymphocytes | 1 | 2004 | 2614 | 0.030 |
Why?
|
Colectomy | 2 | 2014 | 699 | 0.030 |
Why?
|
Anal Canal | 2 | 2010 | 376 | 0.030 |
Why?
|
Fever | 1 | 2004 | 1619 | 0.030 |
Why?
|
Chi-Square Distribution | 3 | 2009 | 3438 | 0.030 |
Why?
|
Sarcoma | 1 | 2007 | 1806 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2017 | 298 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2019 | 948 | 0.030 |
Why?
|
Adolescent | 8 | 2016 | 89244 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9442 | 0.030 |
Why?
|
Risk Factors | 3 | 2017 | 74976 | 0.030 |
Why?
|
Mesenteric Veins | 1 | 1995 | 87 | 0.030 |
Why?
|
Tracheoesophageal Fistula | 1 | 1996 | 131 | 0.030 |
Why?
|
Hospitals | 1 | 2008 | 3904 | 0.030 |
Why?
|
Genes, p16 | 1 | 2015 | 159 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2015 | 2960 | 0.030 |
Why?
|
Blood Proteins | 1 | 1980 | 1191 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 1 | 1989 | 2442 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2015 | 575 | 0.030 |
Why?
|
Videotape Recording | 1 | 2016 | 335 | 0.030 |
Why?
|
United States | 6 | 2017 | 73186 | 0.030 |
Why?
|
Preoperative Period | 1 | 2016 | 565 | 0.030 |
Why?
|
Cholecystostomy | 1 | 1994 | 54 | 0.030 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2015 | 304 | 0.030 |
Why?
|
Ursodeoxycholic Acid | 1 | 1993 | 81 | 0.030 |
Why?
|
Duodenal Neoplasms | 1 | 2014 | 114 | 0.030 |
Why?
|
Bile Duct Diseases | 1 | 1993 | 98 | 0.030 |
Why?
|
Advisory Committees | 1 | 2017 | 797 | 0.030 |
Why?
|
Hospitals, General | 1 | 2017 | 810 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 710 | 0.030 |
Why?
|
Carcinoma | 1 | 2004 | 2340 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1988 | 2488 | 0.020 |
Why?
|
Kidney | 2 | 2006 | 7058 | 0.020 |
Why?
|
Reference Values | 1 | 1999 | 4940 | 0.020 |
Why?
|
Calibration | 1 | 2014 | 822 | 0.020 |
Why?
|
Cholecystography | 1 | 1991 | 42 | 0.020 |
Why?
|
Prednisolone | 1 | 2012 | 327 | 0.020 |
Why?
|
Prolapse | 1 | 2011 | 63 | 0.020 |
Why?
|
Computer Simulation | 2 | 2015 | 6291 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2010 | 6236 | 0.020 |
Why?
|
Tuberculosis | 1 | 2004 | 2029 | 0.020 |
Why?
|
Logistic Models | 2 | 2003 | 13318 | 0.020 |
Why?
|
Markov Chains | 1 | 2014 | 979 | 0.020 |
Why?
|
Gastroscopes | 1 | 2010 | 20 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12095 | 0.020 |
Why?
|
Reference Standards | 1 | 2014 | 1014 | 0.020 |
Why?
|
Survival Analysis | 2 | 2015 | 10115 | 0.020 |
Why?
|
Radiology | 2 | 2017 | 2104 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1586 | 0.020 |
Why?
|
Carmine | 1 | 2009 | 4 | 0.020 |
Why?
|
Alcian Blue | 1 | 2009 | 13 | 0.020 |
Why?
|
Internationality | 1 | 2015 | 1008 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6086 | 0.020 |
Why?
|
Pneumoperitoneum, Artificial | 1 | 2009 | 42 | 0.020 |
Why?
|
Peristalsis | 1 | 1989 | 60 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12562 | 0.020 |
Why?
|
Esophagitis | 1 | 2010 | 164 | 0.020 |
Why?
|
Pancrelipase | 1 | 1988 | 7 | 0.020 |
Why?
|
Immunochemistry | 1 | 2008 | 116 | 0.020 |
Why?
|
Histiocytes | 1 | 2009 | 97 | 0.020 |
Why?
|
Surgical Stomas | 1 | 2009 | 45 | 0.020 |
Why?
|
Sincalide | 2 | 1985 | 15 | 0.020 |
Why?
|
Mesentery | 1 | 2009 | 202 | 0.020 |
Why?
|
Foreign-Body Migration | 1 | 2010 | 220 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2017 | 22296 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3441 | 0.020 |
Why?
|
Hyperplasia | 1 | 2011 | 1154 | 0.020 |
Why?
|
Punctures | 1 | 2009 | 372 | 0.020 |
Why?
|
Lactulose | 1 | 1987 | 32 | 0.020 |
Why?
|
Life Expectancy | 1 | 2014 | 1249 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2011 | 1049 | 0.020 |
Why?
|
Diaphragm | 1 | 2009 | 357 | 0.020 |
Why?
|
Starch | 1 | 1987 | 81 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2016 | 2533 | 0.020 |
Why?
|
Colitis | 1 | 2015 | 1242 | 0.020 |
Why?
|
Submandibular Gland | 1 | 2006 | 85 | 0.020 |
Why?
|
Hydrogen | 1 | 1987 | 171 | 0.020 |
Why?
|
Remission Induction | 1 | 2012 | 2408 | 0.020 |
Why?
|
Abscess | 1 | 2010 | 606 | 0.020 |
Why?
|
Atropine | 1 | 1987 | 244 | 0.020 |
Why?
|
Genes, ras | 1 | 2009 | 665 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3813 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1476 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2010 | 994 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5033 | 0.020 |
Why?
|
Abdominal Injuries | 1 | 2009 | 362 | 0.020 |
Why?
|
Sulfobromophthalein | 1 | 1985 | 9 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2009 | 420 | 0.020 |
Why?
|
Databases, Bibliographic | 1 | 2005 | 129 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 2006 | 513 | 0.010 |
Why?
|
Staining and Labeling | 1 | 2009 | 1081 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 1988 | 969 | 0.010 |
Why?
|
Base Sequence | 1 | 2015 | 12430 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4785 | 0.010 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2009 | 620 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 11886 | 0.010 |
Why?
|
Point Mutation | 1 | 2009 | 1596 | 0.010 |
Why?
|
Saliva | 1 | 1988 | 854 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2006 | 1705 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2015 | 3580 | 0.010 |
Why?
|
Fiber Optic Technology | 1 | 2005 | 291 | 0.010 |
Why?
|
Amino Acids | 2 | 1987 | 1716 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2015 | 18068 | 0.010 |
Why?
|
Spleen | 1 | 2009 | 2294 | 0.010 |
Why?
|
Echocardiography, Doppler | 1 | 2007 | 898 | 0.010 |
Why?
|
Cell Count | 1 | 2006 | 1833 | 0.010 |
Why?
|
Dietary Carbohydrates | 1 | 1987 | 896 | 0.010 |
Why?
|
Length of Stay | 2 | 2009 | 6526 | 0.010 |
Why?
|
Genetic Testing | 1 | 2015 | 3591 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8894 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 1994 | 2517 | 0.010 |
Why?
|
North America | 1 | 2005 | 1290 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4879 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2011 | 2241 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1986 | 1209 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2007 | 1426 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10592 | 0.010 |
Why?
|
Fluorouracil | 1 | 2005 | 1655 | 0.010 |
Why?
|
Surgery, Computer-Assisted | 1 | 2007 | 1006 | 0.010 |
Why?
|
Energy Intake | 1 | 1987 | 2146 | 0.010 |
Why?
|
Fasting | 1 | 1986 | 1610 | 0.010 |
Why?
|
Japan | 1 | 2004 | 1418 | 0.010 |
Why?
|
Consensus | 1 | 2009 | 3214 | 0.010 |
Why?
|
Nose | 1 | 1982 | 524 | 0.010 |
Why?
|
Radiotherapy | 1 | 2005 | 1506 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15879 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 9684 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16731 | 0.010 |
Why?
|
Cholesterol | 1 | 1986 | 2913 | 0.010 |
Why?
|
Neutrophils | 1 | 2009 | 3785 | 0.010 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2005 | 1252 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2005 | 2909 | 0.010 |
Why?
|
Technetium Tc 99m Disofenin | 1 | 1991 | 13 | 0.010 |
Why?
|
Imino Acids | 1 | 1991 | 19 | 0.010 |
Why?
|
Organotechnetium Compounds | 1 | 1991 | 133 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1996 | 1737 | 0.010 |
Why?
|
Proteins | 1 | 1985 | 6011 | 0.010 |
Why?
|
Smoking | 1 | 2005 | 9094 | 0.000 |
Why?
|
Protein Binding | 1 | 1980 | 9344 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 2007 | 9213 | 0.000 |
Why?
|
Gastrins | 1 | 1984 | 75 | 0.000 |
Why?
|
Child | 1 | 2011 | 80960 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1993 | 8559 | 0.000 |
Why?
|
Eating | 1 | 1984 | 1542 | 0.000 |
Why?
|
Rats | 1 | 1984 | 23786 | 0.000 |
Why?
|